Subclinical Hyperthyroidism and Cardiovascular System
https://doi.org/10.14341/ket20062238-42
Abstract
The aim of the study was to assess function of cardiovascular system in patients with subclinical hyperthyroidism (SH). We studied 30 women with SH in the age of 40-75 yr, and 20 euthyroid subjects. The average daytime systolic blood pressure was significantly higher in patients than in controls. The patients with SH had increase of average heart rate compared with the control group. The Doppler echocardiography showed that diastolic function was significantly impaired. To assess the thyroid function we studied medical history of 107 patients with atrial fibrillation. The prevalence of thyrotoxicosis in patients with atrial fibrillation was higher than in subjects without them. Serum level TSH level should be measured in all patients with atrial fibrillation.
About the Authors
T BystrovaE Troshina
F Abdulchabirova
L Panchenkova
Kafedra gospital'noy terapii № 1
A Ilyn
L Chirkova
References
1. Дедов И.И., Мельниченко Г.А., Трошина Е.А. и др. Результаты мониторинга йододефицитных заболеваний в Российской Федерации (2000-2005 гг.). М., 2005. С. 34.
2. Фадеев В.В. Заболевания щитовидной железы в регионе легкого йодного дефицита. Москва: Видар, 2005. с. 27.
3. Biondi B., Palmeri E.A., Fazio S. et al. Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients // Journal of Clinical Endocrinology and Metabolism. 2000. V. 85. P. 4701-4705.
4. Campbell A.J., Reinken J., Allan B.C. Thyroid disease in the elderly in the community // Age and Aging. 1981. V. 10. P. 47-52.
5. Canaris G.J., Manowitz N.R., Mayor G., Ridgway E.C. The Colorado thyroid disease prevalence study // Archives of Internal Medicine. 2000. V. 160. P. 526-532.
6. Hollowel J.G., Staehling N.W., Hannon W.H. et al. Serum thyrotropin, thyroxine and thyroid antibodies in the United States population (1988 to 1994): national health and nutrition examination survey (NHANES III) Journal of Clinical Endocrinology and Metabolism, in press.
7. Mercuro G., Panzuto M.G., Bina A. et al. Cardiac function, physical exercise capacity and quality of life during long term thyrotropin - suppressive therapy with levo-thyroxine: effect of individual dose tailoring // Journal of Clinical Endocrinology and Metabolism. 2000. V. 85. P. 159-164.
8. Sawin C.T., Geller A., Wolf P.A. et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons // The New England Journal of Medicine. 1994. V. 331. P. 1249-1252.
9. Sgarbi J.A., Villaca F., Scandiuzzi S. et al. Improvement of cardiac effects of endogenous subclinical hyperthyroidism with methimazol treatment (Abstract). 12th International Thyroid Congress. Kyoto 2000 // Endocr. J. 2000. V. 47. P. 179.
10. Shapiro L.E., Sievert R., Ong L. et al. Minimal cardiac effects in asymptomatic athyreotic patients chronically treated with thyrotropin - suppressive doses of L-thyroxine // Journal of Clinical Endocrinology and Metabolism. 1997. V. 82. P. 2592-2595.
11. Turnbridge W.M.G., Evered D., Hall R. et al. Spectrum of thyroid disease in a community. The Whickham Study // Clinical Endocrinology. 1977. V. 7. P. 481-493.
Review
For citations:
, , , , , Subclinical Hyperthyroidism and Cardiovascular System. Clinical and experimental thyroidology. 2006;2(2):38-42. (In Russ.) https://doi.org/10.14341/ket20062238-42
Views:
559
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
